These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20203227)

  • 1. In utero drugs of abuse exposure testing for newborn twins.
    Wang P; Molina CP; Maldonado JE; Bernard DW
    J Clin Pathol; 2010 Mar; 63(3):259-61. PubMed ID: 20203227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple birth concordance of street drug assays of meconium analysis.
    Lewis D; Moore C; Leikin JB; Kechavarz L
    Vet Hum Toxicol; 1995 Aug; 37(4):318-9. PubMed ID: 8540217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
    Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
    J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
    Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
    J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy in utero ethanol exposure is associated with the use of other drugs of abuse in a high-risk population.
    Shor S; Nulman I; Kulaga V; Koren G
    Alcohol; 2010; 44(7-8):623-7. PubMed ID: 20031369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
    Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
    J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted perinatal drug screening in a rural population.
    O'Connor TA; Bondurant HH; Siddiqui J
    J Matern Fetal Med; 1997; 6(2):108-10. PubMed ID: 9086427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R; McCune S; Feibus K
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meconium for drug testing.
    Maynard EC; Amoruso LP; Oh W
    Am J Dis Child; 1991 Jun; 145(6):650-2. PubMed ID: 1817465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: a twin study.
    Boskovic R; Klein J; Woodland C; Karaskov T; Koren G
    Can J Physiol Pharmacol; 2001 Nov; 79(11):942-5. PubMed ID: 11760096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of drugs in meconium].
    Dahlem P; Bucher HU; Ursprung T; Mieth D; Gautschi K
    Monatsschr Kinderheilkd; 1992 Jun; 140(6):354-6. PubMed ID: 1640947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
    Pichini S; Puig C; Zuccaro P; Marchei E; Pellegrini M; Murillo J; Vall O; Pacifici R; García-Algar O
    Forensic Sci Int; 2005 Oct; 153(1):59-65. PubMed ID: 15923097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of drugs in meconium].
    Dahlem P; Bucher HU; Cuendet D; Mieth D; Gautschi K
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):237-40. PubMed ID: 8474472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alarming prevalence of fetal alcohol exposure in a Mediterranean city.
    Garcia-Algar O; Kulaga V; Gareri J; Koren G; Vall O; Zuccaro P; Pacifici R; Pichini S
    Ther Drug Monit; 2008 Apr; 30(2):249-54. PubMed ID: 18367990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the prevalence of drug misuse by meconium analysis.
    Williamson S; Jackson L; Skeoch C; Azzim G; Anderson R
    Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F291-2. PubMed ID: 16790733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alternative biological materials to detect prenatal exposure to drugs of abuse in the third trimester of pregnancy].
    García-Serra J; Ramis J; Simó S; Joya X; Pichini S; Vall O; García-Algar O
    An Pediatr (Barc); 2012 Nov; 77(5):323-8. PubMed ID: 22513392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meconium drug screening to detect prenatal substance abuse.
    Wildman KM; Mohl V; Houston R; Allerheiligen D
    J Fam Pract; 1996 Nov; 43(5):501-2. PubMed ID: 8917151
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure.
    Colby JM
    Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.